Clinical Trial Detail

NCT ID NCT02222922
Title A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

Advanced Solid Tumor

ovarian cancer

lung non-small cell carcinoma

triple-receptor negative breast cancer


Avelumab + Cofetuzumab pelidotin


Cofetuzumab pelidotin

Age Groups: adult senior

No variant requirements are available.